Using a self-serve kiosk to test for HIV and reduce harm
Part of Infections clinical trials.
This study tests an interactive, self-serve machine (kiosk) to help people access HIV testing and other harm-reduction services more easily. It may help by making testing and support more private and simpler to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 16 years old (or 18+ if you live in Quebec)
- Live in Canada
- Be able to give consent using the kiosk in English or French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study provides safer, low-dead-space syringes to people who inject drugs to help reduce the spread of infections like HIV and hepatitis C. It is designed for people in low- and middle-income countries who use needle exchange programs.
This study is testing a self-test that checks for both HIV and syphilis using a finger-prick sample. It aims to see if the self-test works as well as standard lab testing.
This study tests whether giving at-home HIV and syphilis self-test kits to men who have sex with men (MSM) can help more people learn their status and get linked to care. It also looks at how sharing test results with partners might increase testing and prevent the spread of infections.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This trial studies how to improve access to HIV self-testing kits through private drug shops and pharmacies. It aims to make it easier for people to get tested for HIV.
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.